Events & Conferences

Myocardial Solutions is excited to go to the Global Cardio Oncology Summit in Minneapolis for an exceptional in-person event focusing on the intersection of cardiovascular health and cancer care. This comprehensive curriculum, hosted by the Lillehei Heart Institute and the Masonic Cancer Center at the University of Minnesota, will feature state-of-the-art insights into clinical topics crucial for managing patients with cancer. Local and international experts in cardiology and oncology will gather to explore the latest research advancements and contemporary practices in preventing, diagnosing early, and managing cardiovascular diseases in cancer patients.

Myocardial Solutions is honored to once again participate in the Annual Cardio Meeting on Wednesday, June 19 hosted by Clinico San Carlos University Hospital. We're proud to collaborate with our esteemed MyoStrain clinical partners, Professor Julian Villacastin, Chairman of Cardiology, and Dr. Jose Alberto Agustin Loeches, Chief of Cardiac Imaging, as we continue to advance cardiac care together.

The Cardiology Summit Forum was organized by Myocardial Solutions in partnership with Spanish entity Triplece Innova. The summit was solely focused on MyoStrain, introducing the innovative technology to the larger medical professional community in Madrid. Speakers included head of the Cardiology Service of the Ramón y Cajal University Hospital in Madrid and vice president of the European Society of Cardiology, Dr. José Luis Zamorano; Amedeo Chiribiri, who is a professor of cardiovascular imaging at the British King's College, London; the medical director of Magnetic Resonance and CT of the Hospital Nuestra Señora del Rosario in the capital, Dr. Eliseo Vañó Galván; and the medical director of Myocardial Solutions, Dr. Rafael Rivero. Watch Dr. Eliseo Vañó Galván and Dr. José Luis Zamorano's interview with the General Council of Nursing in Spain by clicking the event title.

SEICAT is a non-profit medical-scientific association, which brings together doctors with professional dedication to cardiothoracic radiology. SEICAT believes in a progressive incorporation of cardiac imaging in thoracic studies, and MyoStrain was presented at the 2021 congress as a featured innovative and rapid cardiac imaging software.

SCMR is a top global conference for physicians, scientists and technologists working to advance the field of cardiovascular magnetic resonance (CMR). Once every year, MSI presents its latest clinical research and insights about MyoStrain to help educate and inform leading physicians of its innovative cardiac solutions.

The European Society of Cardiology (ESC) is an internationally recognized nonprofit organization dedicated to advancing the field of cardiology. New MyoStrain research findings are presented annually, demonstrating the technology's unique clinical utility across multiple cardiac applications.

The American College of Cardiology (ACC) is one of the most well-known organizations in the cardiology space. Their events feature practice-changing research and cutting edge education, where MyoStrain presents innovative findings for the advancement of cardiovascular care.

Society for Cardiovascular Magnetic Resonance (SCMR) is a top global conference for physicians, scientists and technologists working to advance the field of cardiovascular magnetic resonance (CMR). Once every year, MSI presents its latest clinical research and insights about MyoStrain to help educate and inform leading physicians of its innovative cardiac solutions.

The European Society of Cardiology (ESC) is an internationally recognized nonprofit organization dedicated to advancing the field of cardiology. New MyoStrain research findings are presented annually, demonstrating the technology's unique clinical utility across multiple cardiac applications.

The Heart Failure Association (HFA) is a sub-specialty community of ESC focused on improving quality of life and longevity through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research. MyoStrain was presented clinical data supporting its clinical utility for the individualized management of heart failure patients.